-
Publication Venue For
-
Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction..
16:e010252.
2023
-
Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States..
16:e010430.
2023
-
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial..
16:e010259.
2023
-
Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1..
16:e010012.
2023
-
A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction..
16:e010161.
2023
-
Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure..
16:e010069.
2023
-
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial..
16:e010158.
2023
-
Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry..
16:e010176.
2023
-
Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry..
16:e009714.
2023
-
Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure..
16:e010107.
2023
-
Quality of Life Trajectory and Its Mediators in Older Patients With Acute Decompensated Heart Failure Receiving a Multi-Domain Rehabilitation Intervention: Results From the Rehabilitation Therapy in Older Acute Heart Failure Patients Trial..
15:e009695.
2022
-
Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry..
15:e009353.
2022
-
Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019..
15:e009292.
2022
-
Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes..
15:e009279.
2022
-
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial..
15:e009337.
2022
-
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF..
15:e008970.
2022
-
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018..
15:e008943.
2022
-
Quantification of Vasoactive Medications and the "Pharmaco-Mechanical Continuum" in Cardiogenic Shock..
15:e008736.
2022
-
Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review..
15:e008685.
2022
-
Targeting Preload in Heart Failure: Splanchnic Nerve Blockade and Beyond..
15:e009340.
2022
-
Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make..
15:e008982.
2022
-
Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study..
15:e008797.
2022
-
Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT..
14:e008322.
2021
-
Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance..
14:e008403.
2021
-
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry..
14:e008351.
2021
-
Clinical Heart Failure Among Patients With and Without Severe Mental Illness and the Association With Long-Term Outcomes..
14:e008364.
2021
-
Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8+ T-Cell Infiltration After Heart Transplantation..
14:e007982.
2021
-
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure..
14:e008236.
2021
-
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry..
14:e008242.
2021
-
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure..
14:e008284.
2021
-
Measured Versus Estimated Resting Metabolic Rate in Heart Failure With Preserved Ejection Fraction..
14:e007962.
2021
-
Temporal Trends and Clinical Trial Characteristics Associated With the Inclusion of Women in Heart Failure Trial Steering Committees: A Systematic Review..
14:e008064.
2021
-
Trends in Substance Abuse Disorders Among Patients Hospitalized for Heart Failure in the United States..
14:e008147.
2021
-
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction..
14:e008410.
2021
-
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design..
14:e008100.
2021
-
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support..
14:e007957.
2021
-
Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure..
14:e007871.
2021
-
Trends in 30- and 90-Day Readmission Rates for Heart Failure..
14:e008335.
2021
-
Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support..
14:e007937.
2021
-
Renal Denervation for Patients With Heart Failure: Making a Full Circle..
14:e008301.
2021
-
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial..
14:e007034.
2021
-
Extracardiac Abnormalities of Preload Reserve: Mechanisms Underlying Exercise Limitation in Heart Failure with Preserved Ejection Fraction, Autonomic Dysfunction, and Liver Disease..
14:e007308.
2021
-
Kussmaul's Sign in Pulmonary Hypertension Corresponds With Severe Pulmonary Vascular Pathology Rather Than Right Ventricular Diastolic Dysfunction..
14:e007461.
2021
-
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial..
13:e008007.
2020
-
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study..
13:e007814.
2020
-
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure..
13:e007012.
2020
-
The Time Is Now for Sodium Glucose Co-Transporter 2 Inhibitors for Heart Failure: A Call to Overcome Clinical Inertia..
13:e008030.
2020
-
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan..
13:e007829.
2020
-
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey..
13:e007456.
2020
-
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction..
13:e006414.
2020
-
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials..
13:e006605.
2020
-
Biomarkers in Advanced Heart Failure: Implications for Managing Patients With Mechanical Circulatory Support and Cardiac Transplantation..
13:e006840.
2020
-
Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF..
13:e006833.
2020
-
Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure..
13:e006827.
2020
-
Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan..
13:e006946.
2020
-
Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk..
13:e007132.
2020
-
Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy..
13:e006853.
2020
-
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial..
13:e006758.
2020
-
Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial..
13:e006666.
2020
-
Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction..
13:e006645.
2020
-
Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure: Insights From the PAL-HF Trial..
13:e006134.
2020
-
Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure..
13:e006963.
2020
-
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction..
12:e006539.
2019
-
Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry..
12:e006635.
2019
-
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction..
12:e006240.
2019
-
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials..
12:e005809.
2019
-
High-Sensitivity Troponin in Acute Heart Failure Triage..
12:e006241.
2019
-
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction..
12:e006125.
2019
-
Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function..
12:e005552.
2019
-
Rationale and Design of the VITALITY-HFpEF Trial..
12:e005998.
2019
-
Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity..
12:e005171.
2019
-
Association Between Regional Adipose Tissue Distribution and Risk of Heart Failure Among Blacks..
11:e005629.
2018
-
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction..
11:e005288.
2018
-
Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization..
11:e005531.
2018
-
Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation..
11:e005356.
2018
-
Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States..
11:e005400.
2018
-
Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry..
11:e004646.
2018
-
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data..
11:e004644.
2018
-
Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions..
11:e004634.
2018
-
Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?.
11:e004813.
2018
-
Intracardiac Echinococcal Cyst Causing Biventricular Cavity Obliteration..
11:e004830.
2018
-
Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide..
10.
2017
-
Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia..
10.
2017
-
Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis..
10.
2017
-
Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure..
10.
2017
-
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee..
10.
2017
-
Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management)..
10.
2017
-
Precision Medicine for Heart Failure: Lessons From Oncology..
10.
2017
-
Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study..
10.
2017
-
Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation..
10.
2017
-
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients)..
10.
2017
-
Balancing Bleeding and Clotting: The Known Unknowns of Mechanically Assisted Circulation..
10.
2017
-
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design..
10.
2017
-
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial..
10.
2017
-
Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations..
10.
2017
-
Effects of Coping Skills Training on Quality of Life, Disease Biomarkers, and Clinical Outcomes in Patients With Heart Failure: A Randomized Clinical Trial..
10.
2017
-
Rethinking Revascularization in Left Ventricular Systolic Dysfunction..
10.
2017
-
INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure..
9.
2016
-
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)..
9.
2016
-
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure)..
9.
2016
-
Implications of Using Different Definitions on Outcomes in Worsening Heart Failure..
9.
2016
-
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease..
9.
2016
-
Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients..
9.
2016
-
Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry..
9.
2016
-
Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure..
9.
2016
-
Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry..
9.
2016
-
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial..
9.
2016
-
Developing New Treatments for Heart Failure: Focus on the Heart..
9.
2016
-
Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis?.
9.
2016
-
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure..
9.
2016
-
Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women"..
9.
2016
-
Coenzyme Q10 and Heart Failure: A State-of-the-Art Review..
9:e002639.
2016
-
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry..
9:e002444.
2016
-
Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women..
9:e002630.
2016
-
Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure..
9.
2016
-
Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)..
8:1044-1051.
2015
-
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials..
8:997-1005.
2015
-
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure..
8:709-716.
2015
-
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF)..
8:741-748.
2015
-
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice..
8:788-798.
2015
-
Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) Registry..
8:481-488.
2015
-
Population risk prediction models for incident heart failure: a systematic review..
8:438-447.
2015
-
Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training..
8:497-503.
2015
-
Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers..
8:629-635.
2015
-
Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalization..
8:473-480.
2015
-
Transitions of care in heart failure: a scientific statement from the American Heart Association..
8:384-409.
2015
-
Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study..
8:243-251.
2015
-
Exercise training as therapy for heart failure: current status and future directions..
8:209-220.
2015
-
Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design..
8:221-228.
2015
-
Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach..
7:1022-1031.
2014
-
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF..
7:918-925.
2014
-
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction..
7:895-902.
2014
-
GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study..
7:673-679.
2014
-
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction..
7:590-595.
2014
-
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study..
7:580-589.
2014
-
Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial..
7:401-408.
2014
-
Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula..
7:544-546.
2014
-
Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines..
7:251-260.
2014
-
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction..
7:288-299.
2014
-
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study..
7:123-130.
2014
-
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study..
7:76-87.
2014
-
Renal function trajectories and clinical outcomes in acute heart failure..
7:59-67.
2014
-
Valvular heart disease in patients supported with left ventricular assist devices..
7:215-222.
2014
-
Predictors of disease progression in pediatric dilated cardiomyopathy..
6:1214-1222.
2013
-
Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes..
6:1172-1179.
2013
-
Ten-year experience with extended criteria cardiac transplantation..
6:1230-1238.
2013
-
Predictive models in heart failure: who cares?.
6:877-878.
2013
-
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension..
6:953-963.
2013
-
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial..
6:1087-1094.
2013
-
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF..
6:727-732.
2013
-
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF..
6:740-747.
2013
-
Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009..
6:676-684.
2013
-
FGF23 modifies the relationship between vitamin D and cardiac remodeling..
6:817-824.
2013
-
Is there a rationale for antiplatelet therapy in acute heart failure?.
6:869-876.
2013
-
Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study..
6:862-868.
2013
-
Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease..
6:443-450.
2013
-
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial..
6:451-460.
2013
-
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials..
6:461-472.
2013
-
Donor predictors of allograft use and recipient outcomes after heart transplantation..
6:300-309.
2013
-
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure..
6:240-245.
2013
-
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study..
6:203-210.
2013
-
Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial..
6:264-270.
2013
-
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial..
6:47-52.
2013
-
Defining and refining heart failure risk stratification to optimize patient selection for cardiac transplantation..
6:2-3.
2013
-
Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm..
6:e16-e18.
2013
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States..
6:e1-e11.
2013
-
Acute heart failure: perspectives from a randomized trial and a simultaneous registry..
5:735-741.
2012
-
Addressing the 100% of heart failure: a call for complete care of all ages..
5:667-668.
2012
-
Evaluating treatment efficacy by multiple end points in phase II acute heart failure clinical trials: analyzing data using a global method..
5:742-749.
2012
-
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial..
5:688-692.
2012
-
National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry..
5:680-687.
2012
-
Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial..
5:750-758.
2012
-
Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry..
5:693-702.
2012
-
Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training..
5:579-585.
2012
-
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design..
5:653-659.
2012
-
Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft use..
5:475-483.
2012
-
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study..
5:422-429.
2012
-
Testosterone supplementation in heart failure: a meta-analysis..
5:315-321.
2012
-
Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure..
5:167-175.
2012
-
Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy..
5:241-248.
2012
-
Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure..
5:191-201.
2012
-
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy..
5:10-16.
2012
-
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model..
5:63-71.
2012
-
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study..
5:72-78.
2012
-
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study..
4:724-732.
2011
-
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices..
4:779-784.
2011
-
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims..
4:628-636.
2011
-
Quality of care and outcomes in women hospitalized for heart failure..
4:589-598.
2011
-
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure..
4:293-300.
2011
-
Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions..
4:361-368.
2011
-
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling..
4:214-223.
2011
-
Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee..
3:706-714.
2010
-
A global rank end point for clinical trials in acute heart failure..
3:643-646.
2010
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF..
3:596-605.
2010
-
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward..
3:314-325.
2010
-
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies..
3:253-260.
2010
-
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure..
3:7-13.
2010
-
Prognosis of heart failure in the elderly: not an affair of the heart?.
3:2-3.
2010
-
The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era..
2:401-408.
2009
-
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure..
2:320-324.
2009
-
Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005..
2:3-10.
2009
-
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?.
2:56-62.
2009
-
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support..
1:213-219.
2008
-
Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial..
1:170-177.
2008
-
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF..
1:98-106.
2008
-
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)..
1:25-33.
2008
-
Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)..
1:50-57.
2008
-
A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study.
2023
-
Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction.
2018
-
Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
2017
-
Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE.
2014
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
2014